Arbutus Biopharma (ABUS) Revenue & Revenue Breakdown
Arbutus Biopharma Revenue Highlights
Latest Revenue (Y)
$18.14M
Latest Revenue (Q)
$1.73M
Main Segment (Y)
License
Arbutus Biopharma Revenue by Period
Arbutus Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $18.14M | -53.51% |
| 2022-12-31 | $39.02M | 255.11% |
| 2021-12-31 | $10.99M | 58.92% |
| 2020-12-31 | $6.91M | 15.02% |
| 2019-12-31 | $6.01M | 1.88% |
| 2018-12-31 | $5.90M | -44.86% |
| 2017-12-31 | $10.70M | 613.33% |
| 2016-12-31 | $1.50M | -93.97% |
| 2015-12-31 | $24.87M | 65.82% |
| 2014-12-31 | $15.00M | -3.00% |
| 2013-12-31 | $15.46M | 9.05% |
| 2012-12-31 | $14.18M | -13.03% |
| 2011-12-31 | $16.30M | -23.64% |
| 2010-12-31 | $21.35M | 54.95% |
| 2009-12-31 | $13.78M | 42.94% |
| 2008-12-31 | $9.64M | -39.46% |
| 2007-12-31 | $15.92M | 17.05% |
| 2006-12-31 | $13.60M | 2.36% |
| 2005-12-31 | $13.29M | 9.21% |
| 2004-12-31 | $12.17M | 345.43% |
| 2003-12-31 | $2.73M | -46.14% |
| 2002-12-31 | $5.07M | 46.62% |
| 2001-12-31 | $3.46M | 95.68% |
| 2000-12-31 | $1.77M | 55.03% |
| 1999-12-31 | $1.14M | -7.09% |
| 1998-12-31 | $1.23M | - |
Arbutus Biopharma generated $18.14M in revenue during NA 2023, up -53.51% compared to the previous quarter, and up 307.47% compared to the same period a year ago.
Arbutus Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.73M | 12.66% |
| 2024-03-31 | $1.53M | -28.58% |
| 2023-12-31 | $2.15M | -53.95% |
| 2023-09-30 | $4.66M | 0.15% |
| 2023-06-30 | $4.65M | -30.45% |
| 2023-03-31 | $6.69M | 7.08% |
| 2022-12-31 | $6.25M | 4.92% |
| 2022-09-30 | $5.95M | -58.21% |
| 2022-06-30 | $14.24M | 13.19% |
| 2022-03-31 | $12.58M | 292.42% |
| 2021-12-31 | $3.21M | -4.01% |
| 2021-09-30 | $3.34M | 43.41% |
| 2021-06-30 | $2.33M | 10.22% |
| 2021-03-31 | $2.11M | -11.44% |
| 2020-12-31 | $2.39M | 56.66% |
| 2020-09-30 | $1.52M | 0.59% |
| 2020-06-30 | $1.51M | 1.54% |
| 2020-03-31 | $1.49M | -7.85% |
| 2019-12-31 | $1.62M | -47.14% |
| 2019-09-30 | $3.06M | 368.76% |
| 2019-06-30 | $653.00K | -3.83% |
| 2019-03-31 | $679.00K | -59.54% |
| 2018-12-31 | $1.68M | 5.73% |
| 2018-09-30 | $1.59M | 27.57% |
| 2018-06-30 | $1.24M | -13.37% |
| 2018-03-31 | $1.44M | -43.33% |
| 2017-12-31 | $2.53M | -63.23% |
| 2017-09-30 | $6.89M | 563.33% |
| 2017-06-30 | $1.04M | 342.13% |
| 2017-03-31 | $235.00K | -220.51% |
| 2016-12-31 | $-195.00K | -125.19% |
| 2016-09-30 | $774.00K | 150.49% |
| 2016-06-30 | $309.00K | -48.76% |
| 2016-03-31 | $603.00K | -95.25% |
| 2015-12-31 | $12.69M | 212.08% |
| 2015-09-30 | $4.07M | 18.17% |
| 2015-06-30 | $3.44M | -26.53% |
| 2015-03-31 | $4.68M | 7.63% |
| 2014-12-31 | $4.35M | -0.28% |
| 2014-09-30 | $4.36M | 140.86% |
| 2014-06-30 | $1.81M | -59.12% |
| 2014-03-31 | $4.43M | -41.24% |
| 2013-12-31 | $7.54M | 154.86% |
| 2013-09-30 | $2.96M | 6.26% |
| 2013-06-30 | $2.78M | 29.02% |
| 2013-03-31 | $2.16M | -43.00% |
| 2012-12-31 | $3.79M | 22.23% |
| 2012-09-30 | $3.10M | -12.99% |
| 2012-06-30 | $3.56M | -0.37% |
| 2012-03-31 | $3.57M | -7.50% |
| 2011-12-31 | $3.86M | -3.68% |
| 2011-09-30 | $4.01M | -11.91% |
| 2011-06-30 | $4.55M | 1.84% |
| 2011-03-31 | $4.47M | -32.86% |
| 2010-12-31 | $6.66M | -33.84% |
| 2010-09-30 | $10.06M | 357.85% |
| 2010-06-30 | $2.20M | -9.17% |
| 2010-03-31 | $2.42M | -46.06% |
| 2009-12-31 | $4.48M | 46.30% |
| 2009-09-30 | $3.07M | -5.79% |
| 2009-06-30 | $3.25M | 42.63% |
| 2009-03-31 | $2.28M | 54.99% |
| 2008-12-31 | $1.47M | -63.04% |
| 2008-09-30 | $3.98M | 60.73% |
| 2008-06-30 | $2.48M | 33.69% |
| 2008-03-31 | $1.85M | -56.66% |
| 2007-12-31 | $4.28M | - |
Arbutus Biopharma generated $1.73M in revenue during Q2 2024, up 12.66% compared to the previous quarter, and up 25.81% compared to the same period a year ago.
Arbutus Biopharma Revenue Breakdown
Arbutus Biopharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Non-Cash Royalty | $3.87M | $7.65M | $6.11M | $3.40M | - |
| License | $10.70M | $26.00M | $4.67M | - | - |
| Collaboration And Contracts | - | - | - | $3.52M | $4.36M |
| Royalty | - | - | - | - | $296.80K |
Arbutus Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (73.45%), and Non-Cash Royalty (26.55%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Mar 19 | Dec 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Cash Royalty | $593.00K | $1.20M | $723.00K | $766.00K | $1.18M | $2.26M | $2.35M | $1.69M | $1.36M | $2.15M | $1.86M | $1.14M | $959.00K | - | - | - | - | - | - | - |
| License | $695.00K | $400.00K | $3.20M | $3.00M | $4.10M | $2.40M | $11.02M | $9.63M | $992.00K | $55.00K | $22.00K | $59.00K | $971.00K | - | - | - | - | - | - | - |
| Collaboration And Contracts | - | - | - | - | - | $3.98M | $827.00K | $825.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Royalty | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $696.00K | $689.00K | $82.50K | $1.50M | $31.00K | $61.00K |
Arbutus Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: License (53.96%), and Non-Cash Royalty (46.04%).
ABUS Revenue FAQ
What is Arbutus Biopharma’s yearly revenue?
Arbutus Biopharma's yearly revenue for 2023 was $18.14M, representing a decrease of -53.51% compared to 2022. The company's yearly revenue for 2022 was $39.02M, representing an increase of 255.11% compared to 2021. ABUS's yearly revenue for 2021 was $10.99M, representing an increase of 58.92% compared to 2020.
What is Arbutus Biopharma’s quarterly revenue?
Arbutus Biopharma's quarterly revenue for Q2 2024 was $1.73M, a 12.66% increase from the previous quarter (Q1 2024), and a -62.89% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.53M, a -28.58% decrease from the previous quarter (Q4 2023), and a -77.09% decrease year-over-year (Q1 2023). ABUS's quarterly revenue for Q4 2023 was $2.14M, a -53.95% decrease from the previous quarter (Q3 2023), and a -65.65% decrease year-over-year (Q4 2022).
What is Arbutus Biopharma’s revenue growth rate?
Arbutus Biopharma's revenue growth rate for the last 3 years (2021-2023) was 65.10%, and for the last 5 years (2019-2023) was 201.80%.
What are Arbutus Biopharma’s revenue streams?
Arbutus Biopharma's revenue streams in c 23 are Non-Cash Royalty, and License. Non-Cash Royalty generated $3.87M in revenue, accounting 26.55% of the company's total revenue, down -49.47% year-over-year. License generated $10.7M in revenue, accounting 73.45% of the company's total revenue, down -58.85% year-over-year.
What is Arbutus Biopharma’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Arbutus Biopharma was License. This segment made a revenue of $10.7M, representing 73.45% of the company's total revenue.